S Africa urges WTO pro-health TRIPs move

31 October 2001

The World Trade Organization ministerial meeting in Qatar this monthshould revise the WTO Trade-Related Aspects of Intellectual Property Rights agreement, to "allow countries from the south to gain better access to affordable medicines to ensure universal health care is not a luxury but a human right," South African Health Minister, Manto Tshabalala-Msimang, has said. "It is a crime against humanity for poor people to die because life-saving medicines are too expensive," she added.

Her statement came after WTO officials, meeting last month in Geneva, Switzerland, ahead of the Qatar conference, failed to reach a compromise on demands from developing countries that the ministerial meeting should include a declaration that nothing in TRIPS should stop governments taking measures to protect public health.

Dr Tshabalala-Msimang noted that TRIPS does allow countries to obtain cheaper generic drugs in cases of national health emergencies (a provision which South Africa has so far failed to exploit to deal with its HIV/ AIDS epidemic), but claimed that the drug industry "continues to intimidate and penalize those countries that explore the use of these legitimate clauses."

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Companies featured in this story

More ones to watch >


Today's issue

Company Spotlight